Legal, Regulatory Matters and Contingencies (Details) $ in Thousands				1 Months Ended				2 Months Ended	9 Months Ended
	Jan. 14, 2020 USD ($)	May 22, 2019 USD ($)	May 10, 2019 company employee	Aug. 31, 2019 USD ($)	Oct. 31, 2018 item	Dec. 31, 2016 company	Nov. 30, 2016 item	Jun. 30, 2019 USD ($)	Mar. 31, 2020 USD ($) Distributor lawsuit tranche state product	Feb. 29, 2020 product	Jun. 18, 2018 product	Jun. 07, 2018 product	Oct. 31, 2017 product	Oct. 06, 2017 product
Legal, Regulatory Matters and Contingencies
Settlement payment									$ 9,400
Reimbursement of overpayment									$ 8,100
State Attorneys General Inquiry into The Generic Pharmaceutical Industry
Legal, Regulatory Matters and Contingencies
Number of drugs | product													13
Number of officers | employee			1
Number of manufacturers and distributors | company			33			6
State Attorneys General Inquiry into The Generic Pharmaceutical Industry | Doxycycline Monohydrate
Legal, Regulatory Matters and Contingencies
Number of drugs | product													1
Government Pricing
Legal, Regulatory Matters and Contingencies
Settlement payment		$ 9,400
Reimbursement of overpayment				$ 8,100
Private Antitrust and Consumer Protection Litigation
Legal, Regulatory Matters and Contingencies
Number of drugs | product									18	135	15	14		6
Number of manufacturers and distributors | Distributor									30
Number of lawsuits | lawsuit									100
Number of Tranches | tranche									3
Number of States | state									49
Shareholder Litigation
Legal, Regulatory Matters and Contingencies
Number of officers | item					2		2
Litigation settlement amount payable to other party	$ 600							$ 300